Medline references for link between Maillard reaction and Alzheimer's disease.

• Nat Genet 1994 Mar;6(3):251-5: Felsenstein KM; Hunihan LW; Roberts SB
  Altered cleavage and secretion of a recombinant beta-APP bearing the Swedish familial Alzheimer's disease mutation.
  
• Biochem Biophys Res Commun 1990 Sep 28;171(3):1015-21: Godfroid E; Octave JN
  Glycosylation of the amyloid peptide precursor containing the Kunitz protease inhibitor domain improves the inhibition of trypsin.
  
• Nature 1995 Mar 23;374(6520):316: Smith MA; Sayre LM; Vitek MP; Monnier VM; Perry G
  Early AGEing and Alzheimer's [letter]
  
• Nature 1994 Jul 28;370(6487):247-8: Harrington CR; Colaco CA
  Alzheimer's disease. A glycation connection [news]
  
• Proc Natl Acad Sci U S A 1994 May 24;91(11):4766-70: Vitek MP; Bhattacharya K; Glendening JM; Stopa E; Vlassara H; Bucala R; Manogue K; Cerami A
  Advanced glycation end products contribute to amyloidosis in Alzheimer disease.
  
• Brain Res Mol Brain Res 1993 Jul;19(1-2):171-4: Saito F; Yanagisawa K; Miyatake T
  Soluble derivatives of beta/A4 amyloid protein precursor in human cerebrospinal fluid are both N- and O-glycosylated.
  
• Ann N Y Acad Sci 1994 Nov 17;738:447-54: Smith MA; Richey PL; Taneda S; Kutty RK; Sayre LM; Monnier VM; Perry G
  Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease.
  
• Proc Natl Acad Sci U S A 1994 Jun 7;91(12):5710-4: Smith MA; Taneda S; Richey PL; Miyata S; Yan SD; Stern D; Sayre LM; Monnier VM; Perry G
  Advanced Maillard reaction end products are associated with Alzheimer disease pathology.